Mar 19 |
Synlogic, Inc. (SYBX) Reports Q4 Loss, Tops Revenue Estimates
|
Mar 19 |
Synlogic GAAP EPS of -$1.71 misses by $0.74, revenue of $2.77M beats by $0.04M
|
Mar 19 |
Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results
|
Feb 20 |
Synlogic Adopts Limited Duration Stockholders Rights Plan
|
Feb 9 |
Synlogic shares crater amid company shut down, failed drug study
|
Feb 9 |
PayPal downgraded, United Airlines upgraded: Wall Street's top analyst calls
|
Feb 8 |
Synlogic to discontinue lead drug program, cease operations
|
Feb 8 |
Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update
|
Feb 2 |
Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria
|
Jan 16 |
Sidoti Events, LLC's Virtual January Micro-Cap Conference
|